Back
Amneal Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
69
AMRX
Amneal Pharmaceuticals
Last Price:
8.19
Seasonality Move:
8.01%
Sell
50
NBY
NovaBay Pharmaceuticals
Last Price:
0.70
Seasonality Move:
-18.64%
Buy
69
Amneal Pharmaceuticals (AMRX)
is a Buy
Is Amneal Pharmaceuticals a Buy, Sell or Hold?
- The current Amneal Pharmaceuticals [AMRX] share price is $8.35. The Score for AMRX is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- AMRX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.73. The Score for NBY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AMRX Stock Price Chart
What is Amneal Pharmaceuticals's stock price today?
-
The Amneal Pharmaceuticals share price today is $8.35
The current trend is moderately bearish and AMRX is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.73
The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
AMRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.13 | Buy |
Relative Strength Index (14 RSI): | 49.13 | Sell |
Chaikin Money Flow: | -378408 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.35 - 8.69) | Sell |
Bollinger Bands (100): | (6.61 - 8.15) | Buy |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 59.35 | Buy |
Chaikin Money Flow: | 367837 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.44 - 0.64) | Buy |
Bollinger Bands (100): | (0.46 - 3.26) | Sell |
AMRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.59 | Sell |
20-day SMA: | 8.55 | Sell |
50-day SMA: | 8 | Buy |
200-day SMA: | 6.52 | Buy |
8-day EMA: | 8.5 | Sell |
20-day EMA: | 8.46 | Sell |
50-day EMA: | 8.05 | Buy |
200-day EMA: | 6.59 | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.64 | Buy |
20-day SMA: | 0.54 | Buy |
50-day SMA: | 0.71 | Buy |
200-day SMA: | 3.55 | Sell |
8-day EMA: | 0.66 | Buy |
20-day EMA: | 0.6 | Buy |
50-day EMA: | 0.91 | Sell |
200-day EMA: | 7.97 | Sell |
Amneal Pharmaceuticals Earnings Growth & AMRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.04 per share, an increase this year of $0.01 per share, and an increase next year of $0.10 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Amneal Pharmaceuticals Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |